Hormone therapy suspension and mammography in Women's Health Initiative clinical trials
- PMID: 20083839
- DOI: 10.7326/0003-4819-152-2-201001190-00022
Hormone therapy suspension and mammography in Women's Health Initiative clinical trials
Comment on
-
Short-term hormone therapy suspension and mammography recall: a randomized trial.Ann Intern Med. 2009 Jun 2;150(11):752-65. doi: 10.7326/0003-4819-150-11-200906020-00003. Ann Intern Med. 2009. PMID: 19487710 Free PMC article. Clinical Trial.
Similar articles
-
Summaries for patients. Mammogram recall rates after stopping hormone therapy.Ann Intern Med. 2009 Jun 2;150(11):I28. doi: 10.7326/0003-4819-150-11-200906020-00001. Ann Intern Med. 2009. PMID: 19487707 No abstract available.
-
A comparative review of the risks and benefits of hormone replacement therapy regimens.Am J Obstet Gynecol. 2004 Apr;190(4):1141-67. doi: 10.1016/j.ajog.2003.09.033. Am J Obstet Gynecol. 2004. PMID: 15118656 Review.
-
After the Women's Health Initiative: decision making and trust of women taking hormone therapy.Womens Health Issues. 2005 Jul-Aug;15(4):187-95. doi: 10.1016/j.whi.2005.03.003. Womens Health Issues. 2005. PMID: 16051110
-
NIH asks participants in Women's Health Initiative estrogen-alone study to stop study pills, begin follow-up phase.South Med J. 2004 Apr;97(4):425-6. doi: 10.1097/01.SMJ.0000125549.20351.BB. South Med J. 2004. PMID: 15108846 No abstract available.
-
Controversies in women's health maintenance.Am Fam Physician. 1997 Mar;55(4):1283-90. Am Fam Physician. 1997. PMID: 9092289 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical